FDA Adverse Event Injury Summary report: N

NATRELLE SALINE IMPLANT

MDR report key: 3874163 · Received June 11, 2014

Report

Report Number
MW5036595
Event Type
Injury
Date Received
June 11, 2014
Date of Event
May 27, 2014
Report Date
June 10, 2014
Manufacturer
ALLERGAN
Product Code
FWM
Adverse Event
Yes
Report Source
Voluntary report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

ANAPLASTIC LARGE CELL LYMPHOMA (ALCL). BREAST IMPLANT RELATED. DISCOVERED UPON REMOVING BREAST IMPLANT CAPSULE AND SEROMA FLUID FROM RIGHT BREAST IN PT WHO HAD TEXTURED SALINE-FILLED ALLERGAN IMPLANTS PLACED FOR COSMETIC BREAST ENLARGEMENT IN (B)(6) 2009. PT NOTICED BREAST ASYMMETRY IN SUMMER OF 2013 WHICH PROGRESSED TO RIGHT BREAST NOTICEABLY LARGER THAN LEFT SIDE WITH ULTRASOUND STUDY DONE ON (B)(6) 2014 SHOWING WHAT APPEARED TO BE FLUID AROUND THE RIGHT IMPLANT - POSSIBLE DEFLATION. THIS IMPLANT WAS INTACT UPON REMOVAL BUT HAD A LARGE SURROUNDING SEROMA. BECAUSE OF SUSPICION FOR ALCL, A RIGHT BREAST IMPLANT TOTAL CAPSULECTOMY AND IMPLANT REMOVAL WAS DONE. CAPSULE AND SEROMA FLUID SPECIMENS SENT FOR HISTOLOGY/PATHOLOGY EVALUATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
344269 NATRELLE SALINE IMPLANT SALINE IMPLANT FWM ALLERGAN 168 NATRELLE SALINE- FILLED

Patients

Seq Age Sex Outcome Treatment
1 49 YR Other